ICD-10-CM Billable Code

E20.812

Autoimmune hypoparathyroidism

Clinical Classification Guidelines

Code First

  • , if applicable, underlying condition such as:
  • autoimmune polyglandular failure (E31.0)
  • Schmidt's syndrome (E31.0)

Medical Intelligence & Overview

Autoimmune hypoparathyroidism is a rare condition where the body's immune system mistakenly attacks the parathyroid glands, leading to inadequate production of parathyroid hormone (PTH). This hormone plays a crucial role in regulating calcium and phosphorus levels in the blood. When PTH levels are low, it can result in imbalanced calcium levels, causing various health issues. Recognized under ICD-10 code E20.812, this disorder requires awareness of its causes, symptoms, diagnosis methods, and potential treatment options to effectively manage the condition.

Causes & Symptoms

Clinical Causes: Autoimmune response where the immune system targets parathyroid tissue Genetic predisposition or familial history of autoimmune diseases Associated autoimmune conditions, such as autoimmune polyendocrine syndromes Infections or other factors that may trigger autoimmune activity Post-surgical damage to parathyroid glands (although this is more common in other types of hypoparathyroidism)

Key Symptoms: Muscle cramps and spasms (tetany) Numbness or tingling sensations, especially around the mouth and in the extremities Fatigue and weakness Mood changes, including irritability or anxiety Dry skin and brittle nails Potential seizures due to low calcium levels Hair loss or coarse hair texture Difficulty concentrating or cognitive disturbances

Diagnostic & Treatment

Diagnosis Path: Diagnosis of autoimmune hypoparathyroidism involves a combination of clinical evaluation and laboratory tests. Key diagnostic steps include: - Blood tests revealing low levels of parathyroid hormone (PTH) - Low serum calcium levels and elevated phosphorus levels - Presence of autoantibodies targeting the parathyroid glands - Imaging studies, such as ultrasound or sestamibi scans, may help assess gland structure if needed - Additional tests to rule out other causes of hypoparathyroidism Early diagnosis is vital to manage symptoms effectively and prevent complications.

Treatment Protocols: Managing autoimmune hypoparathyroidism primarily focuses on correcting calcium and vitamin D deficiencies to maintain stable blood levels. Common treatment approaches include: - Oral calcium supplements to raise calcium levels - Activated vitamin D analogs such as calcitriol to enhance calcium absorption - Regular monitoring of calcium, phosphorus, and PTH levels - Addressing underlying autoimmune activity, potentially with immunosuppressive therapy (though this is tailored to specific cases) - Patient education on symptoms of hypocalcemia and when to seek medical help - In some cases, magnesium supplements may be advised if deficiency is identified Proper treatment plans are individualized and require close coordination with healthcare providers to avoid complications like hypercalcemia or kidney issues.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is E20.812 a billable ICD-10 code?
Yes, E20.812 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report E20.812?
Clinical documentation must specify the nature of Autoimmune hypoparathyroidism and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

autoimmune hypoparathyroidism